Related references
Note: Only part of the references are listed.Angiotensin-(1-7) Decreases Cell Growth and Angiogenesis of Human Nasopharyngeal Carcinoma Xenografts
Nana Pei et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Adenovirus-Mediated Angiotensin II Type 2 Receptor Overexpression Inhibits Tumor Growth of Prostate Cancer In Vivo
Jinlong Li et al.
JOURNAL OF CANCER (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells
Min Liu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Biomarkers in bladder cancer: Translational and clinical implications
Liang Cheng et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
AT2 Receptor and Tissue Injury: Therapeutic Implications
Pawel Namsolleck et al.
CURRENT HYPERTENSION REPORTS (2014)
Role of Two Types of Angiotensin II Receptors in Colorectal Carcinoma Progression
Linyan Zhou et al.
PATHOBIOLOGY (2014)
Discovery and Characterization of Alamandine A Novel Component of the Renin-Angiotensin System
Roberto Queiroga Lautner et al.
CIRCULATION RESEARCH (2013)
Protective arms of the renin-angiotensin-system in neurological disease
Colin Sumners et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system
Robson A. S. Santos et al.
JOURNAL OF ENDOCRINOLOGY (2013)
BCG immunotherapy for bladder cancer-the effects of substrain differences
Christine Gan et al.
NATURE REVIEWS UROLOGY (2013)
Effects of Angiotensin II Type 2 Receptor Overexpression on the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo
Hongyan Du et al.
PLOS ONE (2013)
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
Rizwan Haq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis
Xianwei Wang et al.
APOPTOSIS (2012)
Angiotensin II induces apoptosis in intestinal epithelial cells through the AT2 receptor, GATA-6 and the Bax pathway
Lihua Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Intratracheal Administration of a Nanoparticle-Based Therapy with the Angiotensin II Type 2 Receptor Gene Attenuates Lung Cancer Growth
Atsushi Kawabata et al.
CANCER RESEARCH (2012)
Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury
Yanfei Qi et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Targeting Death Receptor TRAIL-R2 by Chalcones for TRAIL-Induced Apoptosis in Cancer Cells
Ewelina Szliszka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Angiotensin II Type 1 Receptor Expression and Microvessel Density in Human Bladder Cancer
Suguru Shirotake et al.
UROLOGY (2011)
Changes in the renin angiotensin system during the development of colorectal cancer liver metastases
Jaclyn H. Neo et al.
BMC CANCER (2010)
Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis
Masaru Iwai et al.
HYPERTENSION RESEARCH (2009)
Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting IκBα Kinase-NFκB (Publication with Expression of Concern. See vol. 295, pg. 8880, 2020) (Withdrawn Publication. See vol. 296, 2021)
Chen Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells
Hongwei Li et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist
M. J. Simmons et al.
ONCOGENE (2008)
Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer
Michio Kosugi et al.
HUMAN CELL (2007)
Angiotensin II type I receptor antagonist as an angiogenic inhibitor in prostate cancer
Takeo Kosaka et al.
PROSTATE (2007)
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer
M Kosugi et al.
CLINICAL CANCER RESEARCH (2006)
Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival
K Ino et al.
BRITISH JOURNAL OF CANCER (2006)
Intronic enhancement of angiotensin II type 2 receptor transgene expression in vitro and in vivo
HW Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Adenoviral-mediated neuron specific transduction ot angiotensin II type 2 receptors
HW Li et al.
REGULATORY PEPTIDES (2005)
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth
M Fujita et al.
CARCINOGENESIS (2005)
Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors
XL Zhang et al.
HYPERTENSION (2004)
Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells
N Tejera et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Cytokine-stimulated inducible nitric oxide synthase expression in astroglia:: Role of Erk mitogen-activated protein kinase and NF-κB
JS Marcus et al.
GLIA (2003)
Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT(1) and AT(2) receptors
B Rizkalla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Differential regulation of in vivo angiogenesis by angiotensin II receptors
T Walther et al.
FASEB JOURNAL (2003)
Angiotensin AT1 and AT2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation
S Fujiyama et al.
CIRCULATION RESEARCH (2001)
Share Paper
